1. Breast cancer vaccines for treatment and prevention

   • Mary L. Disis
   • Denise L. Cecil

   Review 30 November 2021 Pages: 481 - 489

2. An overview of genetic services delivery for hereditary breast cancer

   • Sonya Reid
   • Lucy B. Spalluto
   • Tuya Pal

   Review 26 January 2022 Pages: 491 - 500

   

3. Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing

   • Phuong Dinh
   • J. Dinny Graham
   • Nirmala Pathmanathan

   Preclinical study 01 December 2021 Pages: 501 - 511

   

4. A tool to predict disparities in the timeliness of surgical treatment for breast cancer patients in the USA

   • Christopher G. Verdone
   • Jennifer A. Bayron
   • Richard J. Bleicher

   Preclinical study 11 January 2022 Pages: 513 - 522

   

5. Predicting the clinical outcomes and benefit from letrozole after 5 years of treatment with aromatase inhibitors for early breast cancer: analysis from CCTG MA.17R

   • Yapeng Li
   • Xueying Zheng
   • Guoyou Qin

   Clinical trial 26 November 2021 Pages: 523 - 533

   

6. Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer

   • Faye Coe
   • Vivek Misra
   • Maria Ekholm

   Clinical trial Open access 29 November 2021 Pages: 535 - 543

7. Factors related to patient-reported cosmetic outcome after breast-conserving therapy for breast cancer

   • A. T. P. M. Brands-Appeldoorn
   • R. C. M. Thomma
   • R. M. H. Roumen

   Clinical trial 29 November 2021 Pages: 545 - 552

   

8. The impact of the COVID-19 pandemic on perceived access to health care and preferences for health care provision in individuals (being) treated for breast cancer

   • Dieuwke R. Mink van der Molen
   • Claudia A. Bargon
   • on behalf of UMBRELLA study group

   Clinical trial 01 December 2021 Pages: 553 - 564

   

9. Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial

   • Nicholas Turner
   • Rebecca A. Dent
   • Mafalda Oliveira

   Clinical trial Open access 03 December 2021 Pages: 565 - 576

   

10. Enrollment of older metastatic breast cancer patients in first-line clinical trials: 9-year experience of the large-scale real-life multicenter French ESME cohort

    • M. Bringuier
    • M. Carton
    • C. Baldini

    Clinical trial 05 January 2022 Pages: 577 - 587

    

11. Does conventional specimen radiography after neoadjuvant chemotherapy of breast cancer help to reduce the rate of second surgeries?

    • Benedikt Schaefgen
    • Annika Funk
    • Michael Golatta

    Clinical trial Open access 08 December 2021 Pages: 589 - 598

    

12. A triple-negative breast cancer surrogate subtype classification that correlates with gene expression subtypes

    • Tae-Kyung Yoo
    • Jun Kang
    • Byung Joo Chae

    Clinical trial 12 January 2022 Pages: 599 - 610

    

13. Circulating lipids and breast cancer prognosis in the Malmö diet and cancer study

    • Sixten Harborg
    • Thomas P. Ahern
    • Signe Borgquist

    Epidemiology Open access 25 November 2021 Pages: 611 - 621

    

14. A case-case analysis of women with breast cancer: predictors of interval vs screen-detected cancer

    • Nickolas Dreher
    • Madeline Matthys
    • Laura J. van’t Veer

    Epidemiology 29 November 2021 Pages: 623 - 629

    

15. Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioning

    • Kelly A. Metcalfe
    • Andrea Eisen
    • Steven A. Narod

    Epidemiology 30 November 2021 Pages: 631 - 641

    

16. Studying the association between breast cancer and renal cell carcinoma

    • Khalid Jazieh
    • Firas Baidoun
    • Jame Abraham

    Epidemiology 02 December 2021 Pages: 643 - 652

    

17. Neighborhood characteristics and breast tumor methylation: using epigenomics to explore cancer outcome disparities

    • Jazib Gohar
    • Whitney L. Do
    • Lauren E. McCullough

    Epidemiology 03 January 2022 Pages: 653 - 663

    

18. Care in the time of COVID-19: impact on the diagnosis and treatment of breast cancer in a large, integrated health care system

    • Annie Tang
    • Elad Neeman
    • on behalf of The Permanente Medical Group Breast Research Collaborative

    Epidemiology 06 January 2022 Pages: 665 - 675

    

19. Yield of flow cytometry in addition to cytology for lymph node sampling in patients with incidental axillary adenopathy without a concurrent diagnosis of primary breast malignancy

    • Roberto Lo Gullo
    • Christophe Cloutier Lambert
    • Donna D’Alessio

    Epidemiology 11 January 2022 Pages: 677 - 683

    

20. Safety of systemic hormone replacement therapy in breast cancer survivors

    • Avrum Z. Bluming

    Letter to the Editor 07 January 2022 Pages: 685 - 686